Blow to Biogen as ALS hope tofersen flunks phase 3 trialAlready struggling to make headway with its recently launched Alzheimer’s drug, Biogen suffered a major late-stage pipeline setback Share XBlow to Biogen as ALS hope tofersen flunks phase 3 trialhttps://pharmaphorum.com/news/blow-to-biogen-as-als-hope-tofersen-flunks-phase-3-trial/
